vs
Side-by-side financial comparison of APOGEE ENTERPRISES, INC. (APOG) and Bio-Techne (TECH). Click either name above to swap in a different company.
APOGEE ENTERPRISES, INC. is the larger business by last-quarter revenue ($351.4M vs $295.9M, roughly 1.2× Bio-Techne). Bio-Techne runs the higher net margin — 12.8% vs 4.7%, a 8.1% gap on every dollar of revenue. On growth, APOGEE ENTERPRISES, INC. posted the faster year-over-year revenue change (1.6% vs -6.4%). Over the past eight quarters, Bio-Techne's revenue compounded faster (4.2% CAGR vs 2.9%).
Apogee Electronics is an American manufacturer of audio interfaces, analog-to-digital and digital-to-analog converters, USB & iOS microphones, and audio production software.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
APOG vs TECH — Head-to-Head
Income Statement — Q4 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $351.4M | $295.9M |
| Net Profit | $16.6M | $38.0M |
| Gross Margin | 22.4% | 64.6% |
| Operating Margin | 7.3% | 18.4% |
| Net Margin | 4.7% | 12.8% |
| Revenue YoY | 1.6% | -6.4% |
| Net Profit YoY | 568.8% | 68.3% |
| EPS (diluted) | $0.78 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $351.4M | — | ||
| Q4 25 | $348.6M | $295.9M | ||
| Q3 25 | $358.2M | — | ||
| Q2 25 | $346.6M | $317.0M | ||
| Q1 25 | $345.7M | $316.2M | ||
| Q4 24 | $341.3M | $297.0M | ||
| Q3 24 | $342.4M | $289.5M | ||
| Q2 24 | $331.5M | $306.1M |
| Q1 26 | $16.6M | — | ||
| Q4 25 | $16.5M | $38.0M | ||
| Q3 25 | $23.6M | — | ||
| Q2 25 | $-2.7M | $-17.7M | ||
| Q1 25 | $2.5M | $22.6M | ||
| Q4 24 | $21.0M | $34.9M | ||
| Q3 24 | $30.6M | $33.6M | ||
| Q2 24 | $31.0M | $40.6M |
| Q1 26 | 22.4% | — | ||
| Q4 25 | 23.8% | 64.6% | ||
| Q3 25 | 23.1% | — | ||
| Q2 25 | 21.7% | 62.7% | ||
| Q1 25 | 21.6% | 67.9% | ||
| Q4 24 | 26.1% | 65.3% | ||
| Q3 24 | 28.4% | 63.2% | ||
| Q2 24 | 29.8% | 66.4% |
| Q1 26 | 7.3% | — | ||
| Q4 25 | 7.1% | 18.4% | ||
| Q3 25 | 7.5% | — | ||
| Q2 25 | 2.0% | -7.5% | ||
| Q1 25 | 1.8% | 12.2% | ||
| Q4 24 | 8.4% | 16.0% | ||
| Q3 24 | 12.3% | 13.8% | ||
| Q2 24 | 12.5% | 15.0% |
| Q1 26 | 4.7% | — | ||
| Q4 25 | 4.7% | 12.8% | ||
| Q3 25 | 6.6% | — | ||
| Q2 25 | -0.8% | -5.6% | ||
| Q1 25 | 0.7% | 7.1% | ||
| Q4 24 | 6.1% | 11.7% | ||
| Q3 24 | 8.9% | 11.6% | ||
| Q2 24 | 9.4% | 13.3% |
| Q1 26 | $0.78 | — | ||
| Q4 25 | $0.77 | $0.24 | ||
| Q3 25 | $1.10 | — | ||
| Q2 25 | $-0.13 | $-0.11 | ||
| Q1 25 | $0.12 | $0.14 | ||
| Q4 24 | $0.96 | $0.22 | ||
| Q3 24 | $1.40 | $0.21 | ||
| Q2 24 | $1.41 | $0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $39.5M | $172.9M |
| Total DebtLower is stronger | $232.3M | $260.0M |
| Stockholders' EquityBook value | $511.8M | $2.0B |
| Total Assets | $1.1B | $2.5B |
| Debt / EquityLower = less leverage | 0.45× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $39.5M | — | ||
| Q4 25 | $41.3M | $172.9M | ||
| Q3 25 | $39.5M | — | ||
| Q2 25 | $32.8M | $162.2M | ||
| Q1 25 | $41.4M | $140.7M | ||
| Q4 24 | $43.9M | $177.5M | ||
| Q3 24 | $51.0M | $187.5M | ||
| Q2 24 | $30.4M | $152.9M |
| Q1 26 | $232.3M | — | ||
| Q4 25 | — | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | $285.0M | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M |
| Q1 26 | $511.8M | — | ||
| Q4 25 | $512.3M | $2.0B | ||
| Q3 25 | $500.2M | — | ||
| Q2 25 | $481.8M | $1.9B | ||
| Q1 25 | $487.9M | $2.0B | ||
| Q4 24 | $522.1M | $2.1B | ||
| Q3 24 | $506.4M | $2.1B | ||
| Q2 24 | $480.0M | $2.1B |
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.1B | $2.5B | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | $2.6B | ||
| Q1 25 | $1.2B | $2.6B | ||
| Q4 24 | $1.2B | $2.7B | ||
| Q3 24 | $917.1M | $2.7B | ||
| Q2 24 | $889.0M | $2.7B |
| Q1 26 | 0.45× | — | ||
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | 0.58× | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $122.5M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 7.8% | — |
| Cash ConversionOCF / Net Profit | 7.37× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $122.5M | — | ||
| Q4 25 | $29.3M | — | ||
| Q3 25 | $57.1M | — | ||
| Q2 25 | $-19.8M | $98.2M | ||
| Q1 25 | $30.0M | $41.1M | ||
| Q4 24 | $31.0M | $84.3M | ||
| Q3 24 | $58.7M | $63.9M | ||
| Q2 24 | $5.5M | $75.5M |
| Q1 26 | — | — | ||
| Q4 25 | $22.9M | — | ||
| Q3 25 | $52.4M | — | ||
| Q2 25 | $-26.9M | $93.3M | ||
| Q1 25 | $19.1M | $31.0M | ||
| Q4 24 | $22.0M | $77.5M | ||
| Q3 24 | $50.2M | $54.7M | ||
| Q2 24 | $-1.8M | $57.5M |
| Q1 26 | — | — | ||
| Q4 25 | 6.6% | — | ||
| Q3 25 | 14.6% | — | ||
| Q2 25 | -7.8% | 29.4% | ||
| Q1 25 | 5.5% | 9.8% | ||
| Q4 24 | 6.4% | 26.1% | ||
| Q3 24 | 14.7% | 18.9% | ||
| Q2 24 | -0.5% | 18.8% |
| Q1 26 | 7.8% | — | ||
| Q4 25 | 1.9% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 2.1% | 1.5% | ||
| Q1 25 | 3.2% | 3.2% | ||
| Q4 24 | 2.6% | 2.3% | ||
| Q3 24 | 2.5% | 3.2% | ||
| Q2 24 | 2.2% | 5.9% |
| Q1 26 | 7.37× | — | ||
| Q4 25 | 1.77× | — | ||
| Q3 25 | 2.41× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 12.08× | 1.82× | ||
| Q4 24 | 1.48× | 2.42× | ||
| Q3 24 | 1.92× | 1.90× | ||
| Q2 24 | 0.18× | 1.86× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
APOG
| Architectural Services | $127.1M | 36% |
| Architectural Metals | $110.0M | 31% |
| Architectural Glass | $67.4M | 19% |
| Performance Surfaces | $54.3M | 15% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
